jump to content jump to footer
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026

NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion

Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of Electronic Solution Supplemented with Portfolio of Tailored Resources Improves Tumor Response Assessment for Patients” at the recent 2026 NCCN Annual Conference.

Their work dives into how their institutional investment into standardizing clinical trial response assessments leveraging mint Lesion has improved operational efficiency and data quality in real, measurable ways since implementation in 2019:

  • 32% reduction in data deficiencies found during internal audits
  • Principal Investigator use increased from 10% (2019) to 78% (2024)
  • Integration with existing clinical research workflows enhanced inter-disciplinary collaboration

Benefits/Outcomes

Data Integrity

  • Quality: Automated calculations
  • Completeness: Fields of information required before sign-offs
  • Record-keeping: Legibility, timestamps
  • Privacy: Access granted to assessments by administrators
  • Reduction in deficiencies found by internal quality assurance audits

Reduce Administrative Burden

  • Automated back-end processes, such as automatically sending assessments to Epic EMR
  • Radiologist, Investigator, and Study Team user groups avoid using manual methods and sending them around for input and sign-offs
  • Share data with trial sponsors more readily

Ease of Use

  • Define a clear workflow among stakeholders to complete assessments
  • Tumor Response Assessments are housed in one location to improve accessibility for clinical staff and audit preparedness
  • Scalable to accommodate increase in assessment volume as well as new protocol criteria and  unique protocol structures

Financial

  • Bill more accurately for assessments
  • An assessment is never 'lost' and has to be redone

Read the full poster by clicking here.

Mint Medical is proud to support Memorial Sloan Kettering Cancer Centers's mission of ending cancer for life and can't wait to see what they accomplish next.

 If you're looking to transform the intersection of clinical imaging data in cancer research and how Mint Lesion can support your research aspirations, let's talk.

 

 

Success Story mintLesion Clinical Trials Standardized Reading Procedures Data Analysis Therapy Response Assessment Structured Reporting

Related Resources

Radiologists participating in a hands-on lung cancer screening workshop using structured reporting software mint Lesion at RÖKO 2026
Interactive hands-on workshop on lung cancer screening according to G-BA guidelines at RÖKO 2026, including structured reporting, double reading workflows, and consensus decision-making
Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026
Radiologist analyzing whole-body MRI scans of multiple myeloma using AI-assisted quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted quantification of bone involvement in multiple myeloma with structured analysis, objective metrics, and longitudinal disease tracking.
AI-Supported Quantification of Bone Involvement in Multiple Myeloma
Radiologists utilize Whole-Body MRI (WB-MRI) as an established imaging method for multiple myeloma staging [1,3]. Because it avoids ionizing…
Radiologist using mint Lesion for structured lung cancer screening reporting and AI-assisted lung nodule assessment
How mint Lesion supports radiologists in the German lung cancer screening program through structured reporting, AI-supported workflows, second reading, and longitudinal patient follow-up.
Lung Cancer Screening in Germany: How mint Lesion Supports Radiologists in Clinical Practice
A New Era of Early Detection — and New Challenges With the introduction of the nationwide lung cancer screening program starting in 2026,…